Bortezomib-Induced Muscle Toxicity in Multiple Myeloma

Employing a patient case study and data from a single-center prospective study, this article suggests that patients with multiple myeloma treated with bortezomib should be closely monitored for signs and symptoms of metabolic myopathy during treatment.

Journal of Neuropathy & Experimental Neurology